<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">sechenov</journal-id><journal-title-group><journal-title xml:lang="en">Sechenov Medical Journal</journal-title><trans-title-group xml:lang="ru"><trans-title>Сеченовский вестник</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2218-7332</issn><issn pub-type="epub">2658-3348</issn><publisher><publisher-name>Сеченовский Университет</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.47093/2218-7332.2020.11.1.49-58</article-id><article-id custom-type="elpub" pub-id-type="custom">sechenov-130</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>INTERNAL MEDICINE</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ВНУТРЕННИЕ БОЛЕЗНИ</subject></subj-group></article-categories><title-group><article-title>Depressive disorder and quality of life in patients with cerebral microangiopathy</article-title><trans-title-group xml:lang="ru"><trans-title>Расстройство депрессивного спектра и качество жизни у пациентов с церебральной микроангиопатией</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5070-926X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воробьева</surname><given-names>О. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vorob’eva</surname><given-names>O. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Воробьева Ольга Владимировна, д-р мед. наук, профессор кафедры нервных болезней, кафедры общей врачебной практики</p><p>ул. Трубецкая, д. 8, стр. 2, г. Москва, 119991</p></bio><bio xml:lang="en"><p>Olga V. Vorob’eva, MD, PhD, DMSc, Professor, Department of Nervous Diseases, Department of General Medical Practice</p><p>8/2, Trubetskaya str., Moscow, 119991</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9935-3962</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Фатеева</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Fateeva</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Фатеева Виктория Вячеславовна, соискатель кафедры нервных болезней</p><p>ул. Трубецкая, д. 8, стр. 2, г. Москва, 119991</p></bio><bio xml:lang="en"><p>Victoria V. Fateeva, Postgraduate, Department of Nervous Diseases</p><p>8/2, Trubetskaya str., Moscow, 119991Tel.: +7 (926) 090-23-55 </p></bio><email xlink:type="simple">v.v.fateeva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Sechenov First Moscow State Medical University (Sechenov University)</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>30</day><month>03</month><year>2020</year></pub-date><volume>11</volume><issue>1</issue><fpage>49</fpage><lpage>58</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Vorob’eva O.V., Fateeva V.V., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Воробьева О.В., Фатеева В.В.</copyright-holder><copyright-holder xml:lang="en">Vorob’eva O.V., Fateeva V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.sechenovmedj.com/jour/article/view/130">https://www.sechenovmedj.com/jour/article/view/130</self-uri><abstract><p>The association between depressive disorder and quality of life of middle-aged patients with cerebral microangiopathy has not been fully investigated.</p><sec><title>Aim</title><p>Aim. Study the association between the depression level and quality of life (QOL) in patients with cerebral microangiopathy.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. In outpatients 45–59 years old (n = 262, 42% men, 58% women) with cerebral microangiopathy and depression, the level of anxiety was assessed using the HADS-A scale, QOL — using the SF-36 questionnaire. According to the severity of depression (HADS-D subscale), the following were distinguished: group 1 (n = 116) — 8–10 points (subclinical) and group 2 (n = 146) — ≥11 points (clinical). To analyze the data used: t-test, correlation coefficient, logistic regression model; odds ratio (OR) and 95% confidence interval (CI).</p></sec><sec><title>Results</title><p>Results. In group 2, the average anxiety score on the HADS-A scale was 14.3 ± 4.6 points, and for anhedonia was – 10.4 ± 4.2 points, which is statistically significantly higher than in group 1: 10.1 ± 4.2 and 7.1 ± 2.6 points, respectively (p &lt; 0.05). The overall QOL score was statistically significantly lower in group 2: according to the physical component of health, 52.4 ± 26.5 vs. 88.8 ± 43.5 in group 1 (p &lt; 0.05) and psychological component 38.5 ± 19.4 vs. 70.8 ± 35.8 in group 1 (p &lt; 0.05). Depression, anxiety and anhedonia are associated with a negative effect on the overall QOL: r = −0.84 (p &lt; 0.05), r = −0.81 (p &lt; 0.05), r = −0.87 (p &lt; 0.05), respectively. This association does not depend on age, obesity, type 2 diabetes mellitus: OR for depression was 2.1; 95% CI (1.8–2.4), p &lt; 0.05; anxiety — 1.9; 95% CI (1.2–2.2), p &lt; 0.05; anhedonia — 2.3; 95% CI (2.1–2.7), p &lt; 0.05, respectively.</p></sec><sec><title>Conclusion</title><p>Conclusion. Clinically significant depression reduces noticeably QOL. An increase in the severity of affective symptoms leads to a deterioration in both the psychological and physical components of QOL. Decreased QOL does not depend on age, obesity, type 2 diabetes mellitus.</p></sec></abstract><trans-abstract xml:lang="ru"><p>Ассоциация между депрессивным расстройством и качеством жизни пациентов среднего возраста с церебральной микроангиопатией исследована не в полной мере.</p><sec><title>Цель</title><p>Цель. Изучить ассоциацию уровня депрессии с показателями качества жизни (КЖ) пациентов с церебральной микроангиопатией.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. У амбулаторных пациентов 45–59 лет (n = 262, 42% мужчин, 58% женщин) с церебральной микроангиопатией и наличием депрессии оценен уровень тревоги с помощью шкалы HADS-А, КЖ – при помощи опросника SF-36. По выраженности депрессии (подшкала HADS-D) выделены: группа 1 (n = 116) – 8–10 баллов (субклиническая) и группа 2 (n = 146) — ≥11 баллов (клиническая). Для анализа данных использован: t-тест, коэффициент корреляции, модель логистической регрессии; отношение шансов (ОШ) и 95% доверительный интервал (ДИ).</p></sec><sec><title>Результаты</title><p>Результаты. В группе 2 средний балл тревоги по шкале HADS-A составил 14,3 ± 4,6 балла, ангедонии – 10,4 ± 4,2 балла, что статистически значимо выше, чем в группе 1: 10,1 ± 4,2 и 7,1 ± 2,6 балла соответственно (р &lt; 0,05). Общий балл КЖ был статистически значимо меньше в группе 2: по физическому компоненту здоровья 52,4 ± 26,5 vs. 88,8 ± 43,5 в группе 1 (р &lt; 0,05) и психологическому компоненту 38,5 ± 19,4 vs. 70,8 ± 35,8 в группе 1 (р &lt; 0,05). Депрессия, тревога и ангедония ассоциированы с негативным влиянием на общее КЖ: r = −0,84 (р &lt; 0,05), r = −0,81 (р &lt; 0,05), r = −0,87 (р &lt; 0,05) соответственно. Эта ассоциация не зависит от возраста, ожирения, наличия сахарного диабета 2-го типа: ОШ для депрессии составило 2,1; 95% ДИ (1,8–2,4), р &lt; 0,05; тревоги — 1,9; 95% ДИ (1,2–2,2), р &lt; 0,05; ангедонии — 2,3; 95% ДИ (2,1–2,7), р &lt; 0,05, соответственно.</p></sec><sec><title>Заключение</title><p>Заключение. Клинически значимая депрессия существенно снижает КЖ. Нарастание выраженности аффективной симптоматики приводит к ухудшению как психологического, так и физического компонента КЖ. Снижение КЖ не зависит от возраста, ожирения, наличия СД 2-го типа.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>депрессия</kwd><kwd>тревога</kwd><kwd>ангедония</kwd><kwd>качество жизни</kwd><kwd>церебральная микроангиопатия</kwd></kwd-group><kwd-group xml:lang="en"><kwd>depression</kwd><kwd>anxiety</kwd><kwd>anhedonia</kwd><kwd>quality of life</kwd><kwd>cerebral microangiopathy</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Вознесенская Т.Г. Депрессии в неврологической практике. Трудный пациент. 2003; 1(2): 26–30.</mixed-citation><mixed-citation xml:lang="en">Voznesenskaya T.G. Depressii v nevrologicheskoi praktike. [Depression in neurological practice]. Trudnyy patsiyent. 2003; 1(2): 26–30 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Воробьева О.В. Клинические особенности депрессии в общемедицинской практике (по результатам программы «Компас»). Consilium Medicum. 2004; 6(2): 154–58.</mixed-citation><mixed-citation xml:lang="en">Vorob’eva O.V. Klinicheskie osobennosti depressii v obshchemeditsinskoi praktike (po rezul’tatam programmy «Kompas»). [Clinical features of depression in general medical practice (according to the results of the «Compas» program)]. Consilium Medicum. 2004; 6(2): 154−58 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Краснов В.Н. Тревожно-депрессивные расстройства у пациентов первичной медицинской сети. Медвестник. 2010. URL: http://mniip-repo.ru/uploads/1332153131.pdf (дата обращения: 10.05.2020).</mixed-citation><mixed-citation xml:lang="en">Krasnov V.N. Trevozhno-depressivnye rasstroistva u patsientov pervichnoi meditsinsko seti. [Anxiety-depressive disorders in patients of the primary medical network]. Medvestnik. 2010 (In Russian). URL: http://mniip-repo.ru/uploads/1332153131.pdf (accessed: 10.05.2020)</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Аlеxоpоulоs G.S., Mеyеrs B.S., Yоung R.С., et al. «Vаsсulаr dеprеssiоn» hypоthеsis. Аrсh Gеn Psyсhiаtry. 1997; 54: 915–22. https://doi.org/10.1001/аrсhpsyс.1997.01830220033006 PMID: 9337771</mixed-citation><mixed-citation xml:lang="en">Аlеxоpоulоs G.S., Mеyеrs B.S., Yоung R.С., et al. «Vаsсulаr dеprеssiоn» hypоthеsis. Аrсh Gеn Psyсhiаtry. 1997; 54: 915–22. https://doi.org/10.1001/аrсhpsyс.1997.01830220033006 PMID: 9337771</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Яхно Н.Н., Левин О.С., Дамулин И.В. Сопоставление клинических и МРТ-данных при дисциркуляторной энцефалопатии. Сообщение 2: когнитивные нарушения. Неврологический журнал. 2001; 6(3): 10–9.</mixed-citation><mixed-citation xml:lang="en">Yakhno N.N., Levin O.S., Damulin I.V. Sopostavlenie klinicheskikh i MRT-dannykh pri distsirkulyatornoi ehntsefalopatii. Soobshchenie 2: kognitivnye narusheniya. [Comparison of clinical and MRI data for discirculatory encephalopathy. Message 2: cognitive impairment]. Nevrologicheskii zhurnal. 2001; 6(3): 10–9 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Harwood D., Hawton K., Hope T., Jacob R. Psychiatric disorder and personality factors associated with suicide in older people: a descriptive and case-control study. Int J Geriatr Psychiatry. 2001; 16(2): 155–65. https://doi.org/10.1002/1099-1166(200102)16:2&lt;155::aid-gps289&gt;3.0.co;2-0 PMID: 11241720</mixed-citation><mixed-citation xml:lang="en">Harwood D., Hawton K., Hope T., Jacob R. Psychiatric disorder and personality factors associated with suicide in older people: a descriptive and case-control study. Int J Geriatr Psychiatry. 2001; 16(2): 155–65. https://doi.org/10.1002/1099-1166(200102)16:2&lt;155::aid-gps289&gt;3.0.co;2-0 PMID: 11241720</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Воробьева О.В. Вальдоксан в терапии депрессии в неврологической практике: результаты российского многоцентрового натуралистического исследования «Резонанс». Журнал неврологии и психиатрии им. С.С. Корсакова. 2012; 112(9): 47–51.</mixed-citation><mixed-citation xml:lang="en">Vorob’eva O.V. Val’doksan v terapii depressii v nevrologicheskoi praktike: rezul’taty rossiiskogo mnogotsentrovogo naturalisticheskogo issledovaniya “Rezonans”. [Valdoxan in the treatment of depression in neurological practice: the results of the Russian multicenter naturalistic study “Resonance”]. S.S. Korsakov Journal of Neurology and Psychiatry. 2012; 112(9): 47–51 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cooper J.A., Arulpragasam A.R., Treadway M.T. Anhedonia in depression: biological mechanisms and computational models. Curr Opin Behav Sci. 2018; 22: 128–35. https://doi.org/10.1016/j.cobeha.2018.01.024 PMID: 29503842</mixed-citation><mixed-citation xml:lang="en">Cooper J.A., Arulpragasam A.R., Treadway M.T. Anhedonia in depression: biological mechanisms and computational models. Curr Opin Behav Sci. 2018; 22: 128–35. https://doi.org/10.1016/j.cobeha.2018.01.024 PMID: 29503842</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Brenes G.A. Anxiety, depression, and quality of life in primary care patients. Prim Care Companion J Clin Psychiatry. 2007; 9(6): 437–43. https://doi.org/10.4088/pcc.v09n0606 PMID: 18185823</mixed-citation><mixed-citation xml:lang="en">Brenes G.A. Anxiety, depression, and quality of life in primary care patients. Prim Care Companion J Clin Psychiatry. 2007; 9(6): 437–43. https://doi.org/10.4088/pcc.v09n0606 PMID: 18185823</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Wardlaw J.M., Smith E.E., Biessels G.J., et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013; 12: 822–38. https://doi.org/10.1016/S1474-4422(13)70124-8 PMID: 23867200</mixed-citation><mixed-citation xml:lang="en">Wardlaw J.M., Smith E.E., Biessels G.J., et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013; 12: 822–38. https://doi.org/10.1016/S1474-4422(13)70124-8 PMID: 23867200</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6): 361–70. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x PMID: 6880820</mixed-citation><mixed-citation xml:lang="en">Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6): 361−70. https://doi.org/10.1111/j.1600-0447.1983.tb09716.x PMID: 6880820</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ware J.E., Snow K.K., Kosinski M., Gandek B. SF-36 Health S vey. Manual and interpretation guide. The Health Institute, New England Medical Center. Boston, Mass. 1993.</mixed-citation><mixed-citation xml:lang="en">Ware J.E., Snow K.K., Kosinski M., Gandek B. SF-36 Health Survey. Manual and interpretation guide. The Health Institute, New England Medical Center. Boston, Mass. 1993.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Меликян Э. Г., Гехт А. Б. Качество жизни больных э ей. Лечебное дело. 2011; 1: 1–9.</mixed-citation><mixed-citation xml:lang="en">Melikyan E.G., Gekht A.B. Kachestvo zhizni bol’nykh ehpilepsiei. [Quality of life of patients with epilepsy]. Lechebnoye delo. 2011; 1: 1–9 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Бойко О.В., Татаринова М.Ю., Попова Е.В. и др. У ние показателей качества жизни больных рассеянным склерозом за 15-летний период. Журнал неврологии и психиатрии им. С.С. Корсакова. Спец выпуски. 2018; 118(8): 23–8. https://doi.org/10.17116/jnevro201811808223</mixed-citation><mixed-citation xml:lang="en">Boyko O.V., Tatarinova M.Yu., Popova E.V., et al. Uluchshenie pokazatelei kachestva zhizni bol’nykh rasseyannym sklerozom za 15-letnii period. [Improving the quality of life of patients with multiple sclerosis over a 15-year period]. S.S. Korsakov Journal of Neurology and Psychiatry. Special issues. 2018; 118(8): 23–8 (In Russian). https://doi.org/10.17116/jnevro201811808223</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Воробьева О.В., Фатеева В.В., Иванова Т.А. Влияние к тивных и аффективных нарушений, ассоциированных с хронической сосудистой мозговой недостаточностью, на качество жизни больных. Журнал неврологии и психиатрии им. С.С. Корсакова. 2014; 114(8): 158–9.</mixed-citation><mixed-citation xml:lang="en">Vorob’eva O.V., Fateeva V.V., Ivanova T.A. Vliyanie kognitivnykh i affektivnykh narushenii, assotsiirovannykh s khronicheskoi sosudistoi mozgovoi nedostatochnost’yu, na kachestvo zhizni bol’nykh. [Influence of cognitive and affective disorders associated with chronic cerebrovascular insufficiency on the quality of life of patients]. S.S. Korsakov Journal of Neurology and Psychiatry. 2014; 114(8): 158–9 (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Baker J.G., Williams A.J., Ionita C.C., et al. Cerebral small vessel disease: cognition, mood, daily functioning, and imaging findings from a small pilot sample. Dement Geriatr Cogn Dis Extra. 2012; 2(1): 169–79. https://doi.org/10.1159/000333482 PMID: 22590477</mixed-citation><mixed-citation xml:lang="en">Baker J.G., Williams A.J., Ionita C.C., et al. Cerebral small vessel disease: cognition, mood, daily functioning, and imaging findings from a small pilot sample. Dement Geriatr Cogn Dis Extra. 2012; 2(1): 169–79. https://doi.org/10.1159/000333482 PMID: 22590477</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Амирджанова В.Н., Горячев Д.В., Коршунов Н.И. и др. П пуляционные показатели качества жизни по опроснику SF-36 (результаты многоцентрового исследования качества жизни «МИРАЖ»). Научно-практическая ревматология. 2008; 46(1): 36–48. https://doi.org/10.14412/1995-4484-2008-852</mixed-citation><mixed-citation xml:lang="en">Amirdjanova V.N., Goryachev D.V., Korshunov N.I., et al. Populyatsionnye pokazateli kachestva zhizni po oprosniku SF-36 (rezul’taty mnogotsentrovogo issledovaniya kachestva zhizni “MIRAZH”). [Population indicators of quality of life according to the SF-36 questionnaire (results of a multicenter study of the quality of life “MIRAGE”)]. Rheumatology Science and Practice. 2008; 46(1): 36–48 (In Russian). https://doi.org/10.14412/1995-4484-2008-852</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Захаров В.В. Депрессия при сосудистых заболеваниях г ного мозга. Эффективная фармакотерапия. Неврология. 3(31). https://umedp.ru/articles/depressiya_pri_sosudistykh_zabolevaniyakh_golovnogo_mozga.html (дата обращения 07.04.2020).</mixed-citation><mixed-citation xml:lang="en">Zakharov V.V. Depressiya pri sosudistykh zabolevaniyakh golovnogo mozga. [Depression in vascular diseases of the brain]. Ehffektivnaya farmakoterapiya. Nevrologiya. 3(31) (In Russian). https://umedp.ru/articles/depressiya_pri_sosudistykh_zabol evaniyakh_golovnogo_mozga.html (accessed 07.04.2020)</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Gorwood P. Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci. 2008; 10(3): 291–99. PMID: 18979942</mixed-citation><mixed-citation xml:lang="en">Gorwood P. Neurobiological mechanisms of anhedonia. Dialogues Clin Neurosci. 2008; 10(3): 291–99. PMID: 18979942</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Höflich A., Michenthaler P., Kasper S., Lanzenberger R. Circuit Mechanisms of Reward, Anhedonia, and Depression. Int J Neuropsychopharmacol. 2019; 22(2): 105–18. https://doi.org/10.1093/ijnp/pyy081 PMID: 30239748</mixed-citation><mixed-citation xml:lang="en">Höflich A., Michenthaler P., Kasper S., Lanzenberger R. Circuit Mechanisms of Reward, Anhedonia, and Depression. Int J Neuropsychopharmacol. 2019; 22(2): 105–18. https://doi.org/10.1093/ijnp/pyy081 PMID: 30239748</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Dai L., Zhou H., Xu X., Zuo Z. Brain structural and functional changes in patients with major depressive disorder: a literature review. PeerJ. 2019; 7: e8170. https://doi.org/10.7717/peerj.8170 PMID: 31803543</mixed-citation><mixed-citation xml:lang="en">Dai L., Zhou H., Xu X., Zuo Z. Brain structural and functional changes in patients with major depressive disorder: a literature review. PeerJ. 2019; 7: e8170. https://doi.org/10.7717/peerj.8170 PMID: 31803543</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Cuijpers P., Koole S.L., van Dijke A., et al. Psychotherapy for s clinical depression: meta-analysis. Br J Psychiatry. 2014; 205(4): 268–74. https://doi.org/10.1192/bjp.bp.113.138784 PMID: 25274315</mixed-citation><mixed-citation xml:lang="en">Cuijpers P., Koole S.L., van Dijke A., et al. Psychotherapy for s clinical depression: meta-analysis. Br J Psychiatry. 2014; 205(4): 268–74. https://doi.org/10.1192/bjp.bp.113.13878 PMID: 25274315</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Barbui C., Cipriani A., Patel V., et al. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry. 2011; 198(1): 11–1. https://doi.org/10.1192/bjp.bp.109.076448 PMID: 21200071</mixed-citation><mixed-citation xml:lang="en">Barbui C., Cipriani A., Patel V., et al. Efficacy of antidepressants and benzodiazepines in minor depression: systematic review and meta-analysis. Br J Psychiatry. 2011; 198(1): 11–1. https://doi.org/10.1192/bjp.bp.109.076448 PMID: 21200071</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
